$TECX
Tectonic Therapeutic, Inc., a clinical stage biotechnology company focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G-protein coupled receptors(GPCRs). It offers GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company's pipeline products include RXFP1 agonist, which is in ongoing phase 1a and 1b for the indication of heart failure with preserved ejection fraction; GPCR antagonist for indication of hereditary hemorrhagic telangiectasia; bi-functional GPCR modulator for indication of fibrosis; and GPCR modulators. Tectonic Therapeutic, Inc. is based in Watertown, Massachusetts.
Healthcare
Sector
Biotechnology
Industry
Alise S. Reicin
CEO
51
Employees
$29.02
Current Price
$5.24M
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 2 weeks | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 1 month | Buys | 0 | 0 | - | - | All Sells |
| Sells | 1 | 1 | $31,950.00 | 1,065 | ||
| 2 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 1 | 2 | $63,000.00 | 2,065 | ||
| 3 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 2 | 7 | $629,561.94 | 21,626 | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
| Date | Insider | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| May 4, 2026 | Ruddy Marcella K. Chief Medical Officer | Sale | 1,065 | $30.00 | $31,950.00 | View Details |
| Apr 1, 2026 | Ruddy Marcella K. Chief Medical Officer | Sale | 1,000 | $31.05 | $31,050.00 | View Details |
| Mar 6, 2026 | Ruddy Marcella K. Chief Medical Officer | Sale | 10,000 | $30.00 | $300,000.00 | View Details |
| Mar 6, 2026 | McNamara Peter Chief Scientific Officer | Sale | 215 | $35.00 | $7,525.00 | View Details |
| Mar 6, 2026 | McNamara Peter Chief Scientific Officer | Sale | 6,047 | $30.00 | $181,410.00 | View Details |
| Mar 3, 2026 | McNamara Peter Chief Scientific Officer | Sale | 1,649 | $22.06 | $36,376.94 | View Details |
| Mar 4, 2026 | McNamara Peter Chief Scientific Officer | Sale | 1,650 | $25.00 | $41,250.00 | View Details |
2 more transactions available โ create a free account to see 12 months of history | ||||||
Upcoming Earnings
Scheduled earnings reports
No upcoming earnings scheduled
Past Earnings
Historical earnings results
EPS
Estimated-$1.11
ActualN/A
Revenue
EstimatedN/A
ActualN/A
1 more earnings records available โ create a free account to see 12 months of history
Related Activity
Cross-company insider connections and cluster buy signals
Insiders Also Active At
Insiders at this company also hold positions or have traded at these companies: